FDA — authorised 23 October 2015
- Application: BLA125513
- Marketing authorisation holder: ALEXION PHARM
- Local brand name: STRENSIQ
- Indication: SOLUTION — INJECTION
- Status: approved
🇺🇸 Strensiq in United States
FDA authorised Strensiq on 23 October 2015
Marketing authorisation
Strensiq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Bone approved in United States
Frequently asked questions
Is Strensiq approved in United States?
Yes. FDA authorised it on 23 October 2015.
Who is the marketing authorisation holder for Strensiq in United States?
ALEXION PHARM holds the US marketing authorisation.